section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Derm: dermatitis

GI: nausea, stomatitis, vomiting, altered taste, diarrhea, dyspepsia

GU: renal impairment

Neuro: confusion, neuropathy

Resp: dyspnea

Interactions

Drug-drug:

Availability

(Generic available)

Route/Dosage

Levoleucovorin Rescue Following High-Dose Methotrexate—Based on a Methotrexate Dose of 12 g/m2 IV Over 4 hr and Concurrent with Hydration and Maintenance of Urine pH 7.0

Levoleucovorin Rescue Following Inadvertent Overdosage of Methotrexate

Palliative Treatment of Advanced Metastatic Colorectal Cancer

US Brand Names

Khapzory

Action

  • The reduced form of folic acid that serves as a cofactor in the synthesis of DNA and RNA; does not require dihydrofolate reductase for activity.
Therapeutic effects:
  • Reversal of toxic effects of folic acid antagonists, including methotrexate, that inhibit dihydrofolate reductase.
  • Improved performance status in patients with colorectal cancer.

Classifications

Therapeutic Classification: antidotes (for methotrexate), vitamins

Pharmacologic Classification: folic acid analogues

Pharmacokinetics

Absorption: IV administration results on complete bioavailability.

Distribution: Transported actively and passively across cell membranes; enters CSF.

Metabolism/Excretion: Extensively converted to tetrahydrofolic derivatives.

Half-Life: Total tetrahydrofolic acid: 5.1 hr.

Time/Action Profile

ROUTEONSETPEAKDURATION
IVunknownend of infusion3–6 hr



Patient/Family Teaching

Pronunciation

lee-vo-loo-koe-VOR-in KAL-see-um